We are pleased with Judge Saylor’s decision, which will ensure that important evidence in the NECC meningitis litigation is preserved.
New York, New York (PRWEB) November 30, 2012
A federal judge in Massachusetts has ruled that meningitis lawsuits filed against the New England Compounding Center (NECC) may proceed, and said evidence in the cases must be preserved, Bernstein Liebhard LLP reports. In a decision announced yesterday, U.S. District Judge Dennis Saylor also said he would consolidate about a dozen meningitis lawsuits currently pending in federal court in Boston that have been filed by alleged victims of NECC epidural steroid injections. NECC had asked Judge Saylor to delay the cases in lieu of a decision next year by the Judicial Panel on Multidistrict Litigation (JPML) on whether all federally-filed meningitis lawsuits pending against the company should be consolidated in a single federal court for pretrial proceeding. (Cole v. New England Compounding Pharmacy, 12- 12066, U.S. District Court, District of Massachusetts)
“We are pleased with Judge Saylor’s decision, which will ensure that important evidence in the NECC meningitis litigation is preserved,” says Bernstein Liebhard LLP, a nationwide law firm that represents people injured by defective drugs and medical devices. The firm is currently offering free fungal meningitis lawsuit evaluations to anyone affected by this outbreak and the NECC epidural steroid recall.
In September, Massachusetts-based NECC announced an epidural steroid recall for 17,000 vials of preservative-free methylprednilosone injections after the drugs were tied to a multistate outbreak of fungal meningitis and other infections. The company voluntarily surrendered its license to operate, and recalled all of its products in October. According to the U.S. Centers for Disease Control (CDC), 510 people in 19 states who received NECC steroids have suffered fungal infections. The count includes 478 cases of fungal meningitis, 36 of which were fatal, in people who received epidural steroid injections to treat back pain. Fourteen peripheral joint infections were reported in patients who received steroid injections in their hips, knees, shoulders and other joints.*
In October, plaintiffs in fungal meningitis lawsuits petitioned the JPML for establishment of a multidistrict litigation in Minnesota federal court. NECC has requested that the litigation be transferred to federal court in Massachusetts. The JPML is expected to hear arguments on the proposed consolidation in January. [In Re: New England Compounding Pharmacy, Inc. Products Liability Litigation, MDL No. 2419 (JPML).]
Victims of the fungal meningitis outbreak linked to NECC’s epidural steroid injections may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing a fungal meningitis lawsuit by visiting Bernstein Liebhard LLP’s website http://www.consumerinjurylawyers.com/. For additional information, contact one of the firm’s fungal meningitis lawyers today at (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP